Douglas F. Levinson, M.D.

Publications

• Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J, Zhang N, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Kendler KS, Freedman R, Dudbridge F, Pe'er I, Hakonarson H, Bergen SE, Fanous AH, Holmans PA, Gejman PV. Am J Psychiatry. 2011; 168 (3): 302-16
• Genome-wide association study of recurrent early-onset major depressive disorder. Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA, Lawson WB, DePaulo JR, Gejman PV, Sanders AR, Johnson JK, Adams P, Chaudhury S, Jancic D, Evgrafov O, Zvinyatskovskiy A, Ertman N, Gladis M, Neimanas K, Goodell M, Hale N, Ney N, Verma R, Mirel D, Holmans P, Levinson DF. Mol Psychiatry. 2011; 16 (2): 193-201
• Genomewide association analysis of symptoms of alcohol dependence in the molecular genetics of schizophrenia (MGS2) control sample. Kendler KS, Kalsi G, Holmans PA, Sanders AR, Aggen SH, Dick DM, Aliev F, Shi J, Levinson DF, Gejman PV. Alcohol Clin Exp Res. 2011; 35 (5): 963-75
• Common variants on chromosome 6p22.1 are associated with schizophrenia. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Crowe RR, Oksenberg JR, Mirel DB, Kendler KS, Freedman R, Gejman PV. Nature. 2009; 460 (7256): 753-7
• Significance levels for studies with correlated test statistics. Shi J, Levinson DF, Whittemore AS. Biostatistics. 2008; 9 (3): 458-66
• A comparison of the familiality of chronic depression in recurrent early-onset depression pedigrees using different definitions of chronicity. Mondimore FM, Zandi PP, MacKinnon DF, McInnis MG, Miller EB, Schweizer B, Crowe RP, Scheftner WA, Weissman MM, Levinson DF, DePaulo JR, Potash JB. J Affect Disord. 2007; 100 (1-3): 171-7
• Bootstrap classification and point-based feature selection from age-staged mouse cerebellum tissues of matrix assisted laser desorption/ionization mass spectra using a fuzzy rule-building expert system. Harrington PB, Laurent C, Levinson DF, Levitt P, Markey SP. Anal Chim Acta. 2007; 599 (2): 219-31
• Data acquisition for meta-analysis of genome-wide linkage studies using the genome search meta-analysis method. Forabosco P, Ng MY, Bouzigon E, Fisher SA, Levinson DF, Lewis CM. Hum Hered. 2007; 64 (1): 74-81
• Genetics of recurrent early-onset major depression (GenRED): final genome scan report. Holmans P, Weissman MM, Zubenko GS, Scheftner WA, Crowe RR, Depaulo JR, Knowles JA, Zubenko WN, Murphy-Eberenz K, Marta DH, Boutelle S, McInnis MG, Adams P, Gladis M, Steele J, Miller EB, Potash JB, Mackinnon DF, Levinson DF. Am J Psychiatry. 2007; 164 (2): 248-58
• Genetics of recurrent early-onset major depression (GenRED): significant linkage on chromosome 15q25-q26 after fine mapping with single nucleotide polymorphism markers. Levinson DF, Evgrafov OV, Knowles JA, Potash JB, Weissman MM, Scheftner WA, Depaulo JR, Crowe RR, Murphy-Eberenz K, Marta DH, McInnis MG, Adams P, Gladis M, Miller EB, Thomas J, Holmans P. Am J Psychiatry. 2007; 164 (2): 259-64
• Investigating the role of p11 (S100A10) sequence variation in susceptibility to major depression. Verma R, Cutler DJ, Holmans P, Knowles JA, Crowe RR, Scheftner WA, Weissman MM, DePaulo JR, Levinson DF, Potash JB. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B (8): 1079-82
• QuickSNP: an automated web server for selection of tagSNPs. Grover D, Woodfield AS, Verma R, Zandi PP, Levinson DF, Potash JB. Nucleic Acids Res. 2007; 35 (Web Server issue): W115-20
• Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. Payne JL, Roy PS, Murphy-Eberenz K, Weismann MM, Swartz KL, McInnis MG, Nwulia E, Mondimore FM, MacKinnon DF, Miller EB, Nurnberger JI, Levinson DF, DePaulo JR, Potash JB. J Affect Disord. 2007; 99 (1-3): 221-9
• Statistical corrections of linkage data suggest predominantly cis regulations of gene expression. Shi J, Siegmund DO, Levinson DF. BMC Proc. 2007: 1 Suppl 1 S145
• Association analyses of the neuregulin 1 gene with schizophrenia and manic psychosis in a Hispanic population. Walss-Bass C, Raventos H, Montero AP, Armas R, Dassori A, Contreras S, Liu W, Medina R, Levinson DF, Pereira M, Leach RJ, Almasy L, Escamilla MA. Acta Psychiatr Scand. 2006; 113 (4): 314-21
• Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Holliday EG, Handoko HY, James MR, McGrath JJ, Nertney DA, Tirupati S, Thara R, Levinson DF, Hayward NK, Mowry BJ, Nyholt DR. Twin Res Hum Genet. 2006; 9 (4): 531-9
• Familial aggregation of illness chronicity in recurrent, early-onset major depression pedigrees. Mondimore FM, Zandi PP, Mackinnon DF, McInnis MG, Miller EB, Crowe RP, Scheftner WA, Marta DH, Weissman MM, Levinson DF, Murphy-Ebenez KP, Depaulo JR, Potash JB. Am J Psychiatry. 2006; 163 (9): 1554-60
• Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, Hou C, Buccola NG, Hale N, Weilbaecher AN, Nertney DA, Olincy A, Green S, Schaffer AW, Smith CJ, Hannah DE, Rice JP, Cox NJ, Martinez M, Mowry BJ, Amin F, Silverman JM, Black DW, Byerley WF, Crowe RR, Freedman R, Cloninger CR, Levinson DF, Gejman PV. Am J Hum Genet. 2006; 78 (2): 315-33
• Is perinatal depression familial? Murphy-Eberenz K, Zandi PP, March D, Crowe RR, Scheftner WA, Alexander M, McInnis MG, Coryell W, Adams P, DePaulo JR, Miller EB, Marta DH, Potash JB, Payne J, Levinson DF. J Affect Disord. 2006; 90 (1): 49-55
• The genetics of depression: a review. Levinson DF, Biol Psychiatry. 2006; 60 (2): 84-92
• Comparison of single-nucleotide polymorphisms and microsatellite markers for linkage analysis in the COGA and simulated data sets for Genetic Analysis Workshop 14: Presentation Groups 1, 2, and 3. Wilcox MA, Pugh EW, Zhang H, Zhong X, Levinson DF, Kennedy GC, Wijsman EM. Genet Epidemiol. 2005: 29 Suppl 1 S7-28
• Direct profiling of the cerebellum by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: A methodological study in postnatal and adult mouse. Laurent C, Levinson DF, Schwartz SA, Harrington PB, Markey SP, Caprioli RM, Levitt P. J Neurosci Res. 2005; 81 (5): 613-21
• GSMA: software implementation of the genome search meta-analysis method. Pardi F, Levinson DF, Lewis CM. Bioinformatics. 2005; 21 (24): 4430-1
• Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. Hahn CG, Umapathy, Wang HY, Koneru R, Levinson DF, Friedman E. J Psychiatr Res. 2005; 39 (4): 355-63
• Meta-analysis in psychiatric genetics. Levinson DF, Curr Psychiatry Rep. 2005; 7 (2): 143-51
• The effect of linkage disequilibrium on linkage analysis of incomplete pedigrees. Levinson DF, Holmans P. BMC Genet. 2005: 6 Suppl 1 S6
• Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder. Sjøholt G, Ebstein RP, Lie RT, Berle JØ, Mallet J, Deleuze JF, Levinson DF, Laurent C, Mujahed M, Bannoura I, Murad I, Molven A, Steen VM. Mol Psychiatry. 2004; 9 (6): 621-9
• Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Holmans P, Zubenko GS, Crowe RR, DePaulo JR, Scheftner WA, Weissman MM, Zubenko WN, Boutelle S, Murphy-Eberenz K, MacKinnon D, McInnis MG, Marta DH, Adams P, Knowles JA, Gladis M, Thomas J, Chellis J, Miller E, Levinson DF. Am J Hum Genet. 2004; 74 (6): 1154-67
• Multicenter linkage study of schizophrenia loci on chromosome 22q. Mowry BJ, Holmans PA, Pulver AE, Gejman PV, Riley B, Williams NM, Laurent C, Schwab SG, Wildenauer DB, Bauché S, Owen MJ, Wormley B, Sanders AR, Nestadt G, Liang KY, Duan J, Ribble R, Norton N, Soubigou S, Maier W, Ewen-White KR, DeMarchi N, Carpenter B, Walsh D, Williams H, Jay M, Albus M, Nertney DA, Papadimitriou G, O'Neill A, O'Donovan MC, Deleuze JF, Lerer FB, Dikeos D, Kendler KS, Mallet J, Silverman JM, Crowe RR, Levinson DF. Mol Psychiatry. 2004; 9 (8): 784-95
• Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Duan J, Martinez M, Sanders AR, Hou C, Saitou N, Kitano T, Mowry BJ, Crowe RR, Silverman JM, Levinson DF, Gejman PV. Am J Hum Genet. 2004; 75 (4): 624-38
• CAG repeat polymorphisms in KCNN3 (HSKCa3) and PPP2R2B show no association or linkage to schizophrenia. Laurent C, Niehaus D, Bauché S, Levinson DF, Soubigou S, Pimstone S, Hayden M, Mbanga I, Emsley R, Deleuze JF, Mallet J. Am J Med Genet B Neuropsychiatr Genet. 2003; 116B (1): 45-50
• Genetics of recurrent early-onset depression (GenRED): design and preliminary clinical characteristics of a repository sample for genetic linkage studies. Levinson DF, Zubenko GS, Crowe RR, DePaulo RJ, Scheftner WS, Weissman MM, Holmans P, Zubenko WN, Boutelle S, Murphy-Eberenz K, MacKinnon D, McInnis MG, Marta DH, Adams P, Sassoon S, Knowles JA, Thomas J, Chellis J. Am J Med Genet B Neuropsychiatr Genet. 2003; 119B (1): 118-30
• Genome scan meta-analysis of schizophrenia and bipolar disorder, part I: Methods and power analysis. Levinson DF, Levinson MD, Segurado R, Lewis CM. Am J Hum Genet. 2003; 73 (1): 17-33
• Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lönnqvist J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoëga T, Helgason T. Am J Hum Genet. 2003; 73 (1): 34-48
• Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI, Craddock N, DePaulo JR, Baron M, Gershon ES, Ekholm J, Cichon S, Turecki G, Claes S, Kelsoe JR, Schofield PR, Badenhop RF, Morissette J, Coon H, Blackwood D, McInnes LA, Foroud T, Edenberg HJ, Reich T, Rice JP, Goate A, McInnis MG, McMahon FJ, Badner JA, Goldin LR, Bennett P, Willour VL, Zandi PP, Liu J, Gilliam C, Juo SH, Berrettini WH, Yoshikawa T, Peltonen L, Lönnqvist J, Nöthen MM, Schumacher J, Windemuth C, Rietschel M, Propping P, Maier W, Alda M, Grof P, Rouleau GA, Del-Favero J, Van Broeckhoven C, Mendlewicz J, Adolfsson R, Spence MA, Luebbert H, Adams LJ, Donald JA, Mitchell PB, Barden N, Shink E, Byerley W, Muir W, Visscher PM, Macgregor S, Gurling H, Kalsi G, McQuillin A, Escamilla MA, Reus VI, Leon P, Freimer NB, Ewald H, Kruse TA, Mors O, Radhakrishna U, Blouin JL, Antonarakis SE, Akarsu N. Am J Hum Genet. 2003; 73 (1): 49-62
• Polymorphisms in the 5'-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression. Duan J, Sanders AR, Molen JE, Martinolich L, Mowry BJ, Levinson DF, Crowe RR, Silverman JM, Gejman PV. Mol Psychiatry. 2003; 8 (11): 901-10
• Tumor necrosis factor haplotype analysis amongst schizophrenia probands from four distinct populations in the Asia-Pacific region. Handoko HY, Nancarrow DJ, Hayward NK, Ohaeri JU, Aghanwa H, McGrath JJ, Levinson DF, Johns C, Walters MK, Nertney DA, Srinivasan TN, Thara R, Mowry BJ. Am J Med Genet B Neuropsychiatr Genet. 2003; 121B (1): 1-6
• No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Levinson DF, Holmans PA, Laurent C, Riley B, Pulver AE, Gejman PV, Schwab SG, Williams NM, Owen MJ, Wildenauer DB, Sanders AR, Nestadt G, Mowry BJ, Wormley B, Bauché S, Soubigou S, Ribble R, Nertney DA, Liang KY, Martinolich L, Maier W, Norton N, Williams H, Albus M, Carpenter EB, DeMarchi N, Ewen-White KR, Walsh D, Jay M, Deleuze JF, O'Neill FA, Papadimitriou G, Weilbaecher A, Lerer B, O'Donovan MC, Dikeos D, Silverman JM, Kendler KS, Mallet J, Crowe RR, Walters M. Science. 2002; 296 (5568): 739-41
• The Lifetime Dimensions of Psychosis Scale (LDPS): description and interrater reliability. Levinson DF, Mowry BJ, Escamilla MA, Faraone SV. Schizophr Bull. 2002; 28 (4): 683-95
• Genetic diversity of the human serotonin receptor 1B (HTR1B) gene. Sanders AR, Cao Q, Taylor J, Levin TE, Badner JA, Cravchik A, Comeron JM, Naruya S, Del Rosario A, Salvi DA, Walczyk KA, Mowry BJ, Levinson DF, Crowe RR, Silverman JM, Gejman PV. Genomics. 2001; 72 (1): 1-14
• Haplotype sharing tests of linkage disequilibrium in a Hutterite asthma data set. Levinson DF, Nolte I, te Meerman GJ. Genet Epidemiol. 2001: 21 Suppl 1 S308-11
• Introduction: Linkage disequilibrium and combined linkage and LD mapping of asthma-related genes. Levinson DF, Genet Epidemiol. 2001: 21 Suppl 1 S290-1
• Protecting the privacy of family members in research. Levinson DF, Reich T, Todd RD, Weissman MM, Crowe RR, DeLisi L, Faraone SV, Folstein S, Pelias MK, Pulver AE, Silverman JM. JAMA. 2001; 285 (15): 1960-1; author reply 1962-3
• Simulation studies of detection of a complex disease in a partially isolated population. Levinson DF, Kirby A, Slepner S, Nolte I, Spijker GT, te Meerman G. Am J Med Genet. 2001; 105 (1): 65-70
• Is akathisia associated with poor clinical response to antipsychotics during acute hospital treatment? Luthra V, Pinninti NR, Yoder K, Musthaq MS, Umapathy C, Levinson DF. Gen Hosp Psychiatry. 2000 Jul-Aug; 22 (4): 276-80
• Evidence for linkage by transmission disequilibrium test analysis of a chromosome 22 microsatellite marker D22S278 and bipolar disorder in a Palestinian Arab population. Mujaheed M, Corbex M, Lichtenberg P, Levinson DF, Deleuze JF, Mallet J, Ebstein RP. Am J Med Genet. 2000; 96 (6): 836-8
• Identification and analysis of error types in high-throughput genotyping. Ewen KR, Bahlo M, Treloar SA, Levinson DF, Mowry B, Barlow JW, Foote SJ. Am J Hum Genet. 2000; 67 (3): 727-36
• Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Levinson DF, Holmans P, Straub RE, Owen MJ, Wildenauer DB, Gejman PV, Pulver AE, Laurent C, Kendler KS, Walsh D, Norton N, Williams NM, Schwab SG, Lerer B, Mowry BJ, Sanders AR, Antonarakis SE, Blouin JL, DeLeuze JF, Mallet J. Am J Hum Genet. 2000; 67 (3): 652-63
• No support for linkage to the bipolar regions on chromosomes 4p, 18p, or 18q in 43 schizophrenia pedigrees. Nancarrow DJ, Levinson DF, Taylor JM, Hayward NK, Walters MK, Lennon DP, Nertney DA, Jones HL, Mahtani MM, Kirby A, Kruglyak L, Brown DM, Crowe RR, Andreasen NC, Black DW, Silverman JM, Mohs RC, Siever LJ, Endicott J, Sharpe L, Mowry BJ. Am J Med Genet. 2000; 96 (2): 224-7
• Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample. Mowry BJ, Ewen KR, Nancarrow DJ, Lennon DP, Nertney DA, Jones HL, O'Brien MS, Thornley CE, Walters MK, Crowe RR, Silverman JM, Endicott J, Sharpe L, Hayward NK, Gladis MM, Foote SJ, Levinson DF. Am J Med Genet. 2000; 96 (6): 864-9
• Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. Martinez M, Goldin LR, Cao Q, Zhang J, Sanders AR, Nancarrow DJ, Taylor JM, Levinson DF, Kirby A, Crowe RR, Andreasen NC, Black DW, Silverman JM, Lennon DP, Nertney DA, Brown DM, Mowry BJ, Gershon ES, Gejman PV. Am J Med Genet. 1999; 88 (4): 337-43
• Psychiatric adverse events during vigabatrin therapy. Levinson DF, Devinsky O. Neurology. 1999; 53 (7): 1503-11
• Treatment of schizoaffective disorder and schizophrenia with mood symptoms. Levinson DF, Umapathy C, Musthaq M. Am J Psychiatry. 1999; 156 (8): 1138-48
• Burden and well-being of caregivers for the severely mentally ill: the role of coping style and social support. Webb C, Pfeiffer M, Mueser KT, Gladis M, Mensch E, DeGirolamo J, Levinson DF. Schizophr Res. 1998; 34 (3): 169-80
• Chromosome 22 workshop. Levinson DF, Coon H. Psychiatr Genet. 1998; 8 (2): 115-20
• Genome scan of schizophrenia. Levinson DF, Mahtani MM, Nancarrow DJ, Brown DM, Kruglyak L, Kirby A, Hayward NK, Crowe RR, Andreasen NC, Black DW, Silverman JM, Endicott J, Sharpe L, Mohs RC, Siever LJ, Walters MK, Lennon DP, Jones HL, Nertney DA, Daly MJ, Gladis M, Mowry BJ. Am J Psychiatry. 1998; 155 (6): 741-50
• A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. Dann J, DeLisi LE, Devoto M, Laval S, Nancarrow DJ, Shields G, Smith A, Loftus J, Peterson P, Vita A, Comazzi M, Invernizzi G, Levinson DF, Wildenauer D, Mowry BJ, Collier D, Powell J, Crowe RR, Andreasen NC, Silverman JM, Mohs RC, Murray RM, Walters MK, Lennon DP, Crow TJ. Psychiatry Res. 1997; 70 (3): 131-43
• Linkage analysis of complex disorders with multiple phenotypic categories: simulation studies and application to bipolar disorder data. Levinson DF, Genet Epidemiol. 1997; 14 (6): 653-8
• Pragmatics and statistics in psychiatric genetics. Levinson DF, Am J Med Genet. 1997; 74 (2): 220-2
• The molecular genetics of schizophrenia: an update. Mowry BJ, Nancarrow DJ, Levinson DF. Aust N Z J Psychiatry. 1997; 31 (5): 704-13
• Family burden of schizophrenia and bipolar disorder: perceptions of relatives and professionals. Mueser KT, Webb C, Pfeiffer M, Gladis M, Levinson DF. Psychiatr Serv. 1996; 47 (5): 507-11
• Penetrance of schizophrenia-related disorders in multiplex families after correction for ascertainment. Levinson DF, Mowry BJ, Sharpe L, Endicott J. Genet Epidemiol. 1996; 13 (1): 11-21
• Detection of vulnerability loci by association and sib-pair methods. Levinson DF, Genet Epidemiol. 1995; 12 (6): 631-5
• Fluphenazine plasma levels, dosage, efficacy, and side effects. Levinson DF, Simpson GM, Lo ES, Cooper TB, Singh H, Yadalam K, Stephanos MJ. Am J Psychiatry. 1995; 152 (5): 765-71
• Delusions in schizophrenia spectrum disorders: diagnostic issues. Gladis MM, Levinson DF, Mowry BJ. Schizophr Bull. 1994; 20 (4): 747-54
• Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Maier W, Lichtermann D, Minges J, Hallmayer J, Heun R, Benkert O, Levinson DF. Arch Gen Psychiatry. 1993; 50 (11): 871-83
• Genetic linkage and schizophrenia: methods, recent findings and future directions. Mowry BJ, Levinson DF. Aust N Z J Psychiatry. 1993; 27 (2): 200-18
• Power to detect linkage with heterogeneity in samples of small nuclear families. Levinson DF, Am J Med Genet. 1993; 48 (2): 94-102
• Schizotypal and paranoid personality disorder in the relatives of patients with schizophrenia and affective disorders: a review. Webb CT, Levinson DF. Schizophr Res. 1993; 11 (1): 81-92
• The treatment and management of neuroleptic malignant syndrome. Gratz SS, Levinson DF, Simpson GM. Prog Neuropsychopharmacol Biol Psychiatry. 1992; 16 (4): 425-43
• Timing of acute clinical response to fluphenazine. Levinson DF, Singh H, Simpson GM. Br J Psychiatry. 1992: 160 365-71
• Pharmacologic treatment of schizophrenia. Levinson DF, Clin Ther. 1991 May-Jun; 13 (3): 326-52
• Defining the schizophrenia spectrum: issues for genetic linkage studies. Levinson DF, Mowry BJ. Schizophr Bull. 1991; 17 (3): 491-514
• Skin conductance orienting response in unmedicated RDC schizophrenic, schizoaffective, depressed, and control subjects. Levinson DF, Biol Psychiatry. 1991; 30 (7): 663-83
• Acute dystonia during fixed-dose neuroleptic treatment. Singh H, Levinson DF, Simpson GM, Lo ES, Friedman E. J Clin Psychopharmacol. 1990; 10 (6): 389-96
• Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. Levinson DF, Simpson GM, Singh H, Yadalam K, Jain A, Stephanos MJ, Silver P. Arch Gen Psychiatry. 1990; 47 (8): 761-8
• Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG. Schizophr Bull. 1990; 16 (1): 31-56
• Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration. Simpson GM, Yadalam KG, Levinson DF, Stephanos MJ, Lo ES, Cooper TB. J Clin Psychopharmacol. 1990; 10 (6): 417-21
• What HMOs should tell their subscribers, and what you can do about it. Levinson DF, Consultant. 1989; 29 (5): 118-20, 123-5
• Exacerbation of panic disorder during propranolol therapy. Levinson DF, Acquaviva J. J Clin Psychopharmacol. 1988; 8 (3): 193-5
• Neuroleptic plasma level may predict response in patients who meet a criterion for improvement. Levinson DF, Simpson GM, Singh H, Cooper TB, Laska EV, Midha KK. Arch Gen Psychiatry. 1988; 45 (9): 878-9
• Twin studies and genetic models of schizophrenia. Levinson DF, Arch Gen Psychiatry. 1988; 45 (9): 876-8
• Schizoaffective mania reconsidered. Levinson DF, Levitt ME. Am J Psychiatry. 1987; 144 (4): 415-25
• Sequelae of neuroleptic malignant syndrome. Levinson DF, Simpson G. Biol Psychiatry. 1987; 22 (2): 237-8
• Toward full disclosure of referral restrictions and financial incentives by prepaid health plans. Levinson DF, N Engl J Med. 1987; 317 (27): 1729-31
• Methylphenidate challenge in a manic boy. Schmidt K, Delaney MA, Jensen M, Levinson DF, Lewitt M. Biol Psychiatry. 1986; 21 (11): 1107-9
• Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'. Levinson DF, Simpson GM. Arch Gen Psychiatry. 1986; 43 (9): 839-48
• Scoring criteria for response latency and habituation in electrodermal research: a critique. Levinson DF, Edelberg R. Psychophysiology. 1985; 22 (4): 417-26
• The skin conductance orienting response in neuroleptic-free schizophrenics: replication of the scoring criteria effect. Levinson DF, Edelberg R, Maricq HR. Biol Psychiatry. 1985; 20 (6): 646-53
• The orienting response in schizophrenia: proposed resolution of a controversy. Levinson DF, Edelberg R, Bridger WH. Biol Psychiatry. 1984; 19 (4): 489-507
• The value of clinical predictions of dangerousness. Levinson DF, Am J Psychiatry. 1983; 140 (5): 657-8
• Recurrent large-group phenomena: studies of an adolescent therapeutic community. Crabtee LH, Levinson DF. Adolesc Psychiatry. 1980: 8 512-28
• Ward tension and staff leadership in a therapeutic community for hospitalized adolescents. Levinson DF, Crabtree LH. Psychiatry. 1979; 42 (3): 220-40